Medtech Acquisition Stock Fundamentals
| MTACWDelisted Stock | USD 0.10 0.00 0.00% |
MedTech Acquisition fundamentals help investors to digest information that contributes to MedTech Acquisition's financial success or failures. It also enables traders to predict the movement of MedTech Stock. The fundamental analysis module provides a way to measure MedTech Acquisition's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to MedTech Acquisition stock.
MedTech |
MedTech Acquisition Company EBITDA Analysis
MedTech Acquisition's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current MedTech Acquisition EBITDA | (8.58 M) |
Most of MedTech Acquisition's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, MedTech Acquisition is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
CompetitionAccording to the company disclosure, MedTech Acquisition reported earnings before interest,tax, depreciation and amortization of (8.58 Million). This is much lower than that of the Metals & Mining sector and significantly lower than that of the Materials industry. The ebitda for all United States stocks is notably higher than that of the company.
MedTech Acquisition Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining MedTech Acquisition's current stock value. Our valuation model uses many indicators to compare MedTech Acquisition value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across MedTech Acquisition competition to find correlations between indicators driving MedTech Acquisition's intrinsic value. More Info.MedTech Acquisition is considered to be number one stock in number of shares shorted category among its peers. It also is considered to be number one stock in ebitda category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value MedTech Acquisition by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.MedTech EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses MedTech Acquisition's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of MedTech Acquisition could also be used in its relative valuation, which is a method of valuing MedTech Acquisition by comparing valuation metrics of similar companies.MedTech Acquisition is currently under evaluation in ebitda category among its peers.
MedTech Fundamentals
| Number Of Shares Shorted | 7.89 K | |||
| EBITDA | (8.58 M) | |||
| Net Income | 5.54 M | |||
| Cash And Equivalents | 25 K | |||
| Total Debt | 2.37 M | |||
| Debt To Equity | 1.77 % | |||
| Cash Flow From Operations | (2.74 M) | |||
| Market Capitalization | 306.25 M | |||
| Total Asset | 20.19 M | |||
| Retained Earnings | (13.27 M) | |||
| Working Capital | (2.14 M) | |||
| Z Score | 75.01 | |||
| Net Asset | 20.19 M |
About MedTech Acquisition Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze MedTech Acquisition's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MedTech Acquisition using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MedTech Acquisition based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.MedTech Acquisition Corporation focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in New York, New York. Medtech Acquisition is traded on NASDAQ Exchange in the United States.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in MedTech Stock
If you are still planning to invest in MedTech Acquisition check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MedTech Acquisition's history and understand the potential risks before investing.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |